AI and Machine Learning solutions trending in the next SmiLe HealthTech Bootcamp Program

SmiLe Incubator

This week seven new companies start the journey towards getting their innovative business ideas investment ready as they join the eighth batch of SmiLe Bootcamp – a 10-week virtual business development program for early-stage HealthTech, MedTech and eHealth companies. This year, many of the solutions are using AI and machine learning to tackle health challenges such as dementia and Alzheimer. At the end of the program the startups will get a unique chance to pitch their business ideas to a jury of investors and industry experts during a virtual Demo Day event.

After a rigorous screening process, the next seven startups to join SmiLe’s Bootcamp program have been selected and, as always, they are demonstrating a very high standard. The innovative solutions range from pro-active stress management platforms and AI- based solutions for remote dental check-ups and improving the diagnosis of cardiovascular disease to using machine learning for early detection of Alzheimer’s, as well as other ground-breaking technologies and tools that improve diagnostics in a number of areas.

The startups will now spend the next 10 weeks developing and perfecting their business ideas and value proposition with the support of SmiLe’s experienced business coaches, all with extensive experience from different areas of the life science industry, as well as other industry experts from across SmiLe’s network. Each startup has also been matched with a dedicated mentor with a relevant background and experience from the industry.

During the program the participants will be sharpening their knowledge in areas like market validation, regulatory strategy, intellectual property, business models, financing, pitching and marketing. This process is facilitated by SmiLe’s exclusive learning management platform – SmiLe Online. The platform allows the participants to attend live workshops, lectures and Q&A sessions, as well as personalised coaching meetings and the community activities, all online.

“Once again, our Bootcamp programme has attracted very interesting companies from many diagnostic areas as well as from different countries. The program basically demands a full-time commitment over 10 weeks, which differentiates it from other similar programs globally. Although this is a big ask, we see the enormous benefits of such a kickstart and looking at our track record, so do the companies”, says Ebba Fåhraeus, CEO of SmiLe.

The program ends with a Demo Day – an online event where the participants will pitch their companies and business ideas to a jury of investors and leading industry experts. The Demo Day will be held on May 19th and it is open to anyone interested in joining. After having completed the Bootcamp program the startups can be qualified to apply for SmiLe’s Incubator program.

The following companies have been selected to this year’s program:


Normera is a simple and secure pro-active stress management platform for individuals to tackle stressors that can result in temporary or long term burn out.


Teladenta provides an AI-supported App for fast remote dental check-ups by dentists. We improve dental health throughout society by making it easier, more comfortable to get dental check-ups and by increasing the awareness for an optimal oral health.


CardEqual’s goal is to use artificial intelligence (AI) algorithms to improve the diagnostics of CVD in women, resulting in better follow-ups and clinical outcomes.


Our mission at SureCapture Technologies is to provide novel diagnostic and therapeutic solutions faster, cheaper and greener.


ADix is developing a non-invasive Alzheimer’s disease diagnostic test in a self-administered smartphone app. Our machine learning methods analyzing cerebral and facial features will enable early detection of Alzheimer’s disease for anyone, anywhere.

Beat Vascular Health

Beat Vascular Health is creating a tool for precise identification of anomalies in the cardiovascular system, based on modelling of industrial systems, to help reduce overadmission of patients, leading to lower healthcare expenditure, workload and patient stress.


Based on a novel technology, Proxiprobes is developing advanced biomolecular diagnostic kits with improved specificity and sensitivity.


For more information:

Visit our website:

Ebba Fåhraeus+46 (0)734000433,